Impact of CMV-Specific Immune Reconstitution at the End of Letermovir Prophylaxis on the Development of Late Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients (INMUNOEND)

NCT06814301 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
123
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Maimónides Biomedical Research Institute of Córdoba